Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Perricaudet

Showing results (61-70 of 174) with videos related to

Pageof 18
Sort By:
Gene Therapy|October 1, 1996
Adenovirus vector-transduced hepatocytes implanted via a preformed collagen/PTFE support persist for at least 4 weeks in vivoE J Kremer, N D Di Falco, P Opolon, et al.
The EMBO Journal|December 30, 1985
In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenovirusesA Ballay, M Levrero, M A Buendia, et al.
Journal of Virology|March 1, 1993
Identification of a short amino acid sequence essential for efficient nuclear targeting of the Epstein-Barr virus nuclear antigen 3AA Le Roux, M Berebbi, M Moukaddem, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
High frequency of specific CD8+ T cells in the tumor and blood is associated with efficient local IL-12 gene therapy of cancerN C Fernandez, J P Levraud, H Haddada, et al.
Oncogene|December 22, 1999
Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2N Foray, V Randrianarison, D Marot, et al.
Annales De Microbiologie|November 1, 1978
[Construction of derivatives of bacteriophage lambdaplac5 vectors permitting the placement of foreign genes under the control of lactose operon promotor of Escherichia Coli (proceedings)]P Tiollais, P Charnay, A Fritsch, et al.
The Journal of General Virology|March 1, 1993
Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarinT Ragot, S Finerty, P E Watkins, et al.
Nature|February 25, 1982
Different mRNAs from the transforming region of highly oncogenic and non-oncogenic human adenovirusesA Virtanen, U Pettersson, J M Le Moullec, et al.
Virology|December 1, 1994
The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoterA Le Roux, B Kerdiles, D Walls, et al.
Virology|May 1, 1989
Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigenO Jean-Jean, M Levrero, H Will, et al.
Pageof 18

Showing results (61-70 of 174) with videos related to

Sort By:
Pageof 18
Gene Therapy|October 1, 1996
Adenovirus vector-transduced hepatocytes implanted via a preformed collagen/PTFE support persist for at least 4 weeks in vivoE J Kremer, N D Di Falco, P Opolon, et al.
The EMBO Journal|December 30, 1985
In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenovirusesA Ballay, M Levrero, M A Buendia, et al.
Journal of Virology|March 1, 1993
Identification of a short amino acid sequence essential for efficient nuclear targeting of the Epstein-Barr virus nuclear antigen 3AA Le Roux, M Berebbi, M Moukaddem, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
High frequency of specific CD8+ T cells in the tumor and blood is associated with efficient local IL-12 gene therapy of cancerN C Fernandez, J P Levraud, H Haddada, et al.
Oncogene|December 22, 1999
Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2N Foray, V Randrianarison, D Marot, et al.
Annales De Microbiologie|November 1, 1978
[Construction of derivatives of bacteriophage lambdaplac5 vectors permitting the placement of foreign genes under the control of lactose operon promotor of Escherichia Coli (proceedings)]P Tiollais, P Charnay, A Fritsch, et al.
The Journal of General Virology|March 1, 1993
Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarinT Ragot, S Finerty, P E Watkins, et al.
Nature|February 25, 1982
Different mRNAs from the transforming region of highly oncogenic and non-oncogenic human adenovirusesA Virtanen, U Pettersson, J M Le Moullec, et al.
Virology|December 1, 1994
The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoterA Le Roux, B Kerdiles, D Walls, et al.
Virology|May 1, 1989
Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigenO Jean-Jean, M Levrero, H Will, et al.
Pageof 18